Echo IQ Highlights US Expansion and Regulatory Plans at Healthcare Conference
EIQ: $0.490 +0.00% · MC: $396M
Echo IQ’s conference presentation outlines its US expansion plans for FDA-cleared EchoSolv AS and regulatory strategy for EchoSolv HF, which remains investigational and is not cleared for US commercial distribution. The update follows the company’s recent appointment of former senior FDA official Dr Vasum Peiris as chief medical officer, effective in January.

Comments